Sumitovant Biopharma and Sumitomo Pharma to acquire outstanding shares of Myovant Sciences
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
Sildenafil for Oral Suspension had annual sales of USD 65 million in the United States according to IQVIA data (IQVIA MAT Aug 2022).
Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
Sildenafil for Oral Suspension (RLD Revatio) had estimated annual sales of US $64 million in the US
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
The consideration includes Rs. 115 crore (on the date of signing) of cash and cash equivalents in the acquired business indicating an Enterprise Value of Rs. 1,885 crore
The two-day meeting in the city was organized in collaboration with the University of Birmingham, Christian Medical College Ludhiana, and Birmingham Clinical Trials Unit
Dr. Bunker will focus on leading Research and Development (R&D) in San Diego, advancing the preclinical pipeline and optimizing the Company’s Integrated Discovery Engine.
Subscribe To Our Newsletter & Stay Updated